CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer clinical trials in the Asia-Pacific region, and the significant investments ...

该研究揭示了一条与 BRCA1/2 合成致死的新通路。 在这项最新研究中，研究团队发现了一个具有与端粒结合蛋白 TRF1/TRF2 类似的 Myb/SANT-like DNA 结合结构 ...

However, BRCA1/2 and other cancer risk genes haven't traditionally been part of the carrier screening panels that are typically offered as part of standard reproductive planning. "So, if you're a ...